. Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry. J Alzheimers Dis. 2014;41(2):441-51. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
AD
(41)
511 ± 185.2
pg/mL
Mass Spectrometry;
Other/Not Specified;
In-house
Aβ42
(CSF)
CTRL-
CNC
(41)
1152 ± 421.2
pg/mL
Mass Spectrometry;
Other/Not Specified;
In-house

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.